Michelle Robertson

Ms. Robertson joined Momenta in May 2017 as Vice President, Financial Planning and Analysis and has served since October 2018 as Chief Financial Officer.  Ms. Robertson is responsible for the oversight of all finance, accounting and treasury. Prior to joining Momenta, Ms. Robertson was Vice President, Oncology Finance for Baxalta, Inc., following its spin-out from Baxter International in July 2015. Before that, Ms. Robertson was at Ironwood Pharmaceuticals as head of Financial Planning and Analysis and Operations, and prior to that, Genzyme Corporation where she held various leadership positions in the Oncology and Biosurgery divisions with Finance and Commercial Operations, focusing on financial analysis for business development, acquisition integrations, and divestitures.